Profile: Supratek Pharma Inc. is a patient and product oriented pharmaceutical company, specializing in the discovery & rapid development of anticancer therapeutics. Our Biotransport™ nanomedicine technology involves the proprietary use of a highly flexible block co-polymer chemistry to produce nanomedicine compositions of diverse molecules. It consists of an active pharmaceutical ingredient with specific polymer combinations resulting in beneficial biological response modification and targeted drug delivery. This technology is applicable to new chemical entities and generic drugs & can be an effective tool for improving pharmacokinetics, bioavailability & provide drug life extension. Biotransport™ compositions incorporate a drug molecule without chemical interactions, the resulting nano-systems, ranging from 10nm to 100nm in size, are formed spontaneously and are thermodynamically stable. SP-MET-X™ technology includes a new library of small molecules that embodies a number of new chemical entities (NCEs) with variable pharmacological properties that inhibit the newly identified pathogenic pathway mediated by the S100 proteins.